Annual Congress Barcelona 2010

Saturday, 18.09.2010
Sunday, 19.09.2010
Monday, 20.09.2010
Tuesday, 21.09.2010
Wednesday, 22.09.2010

Citations should be made in the following way: Authors. Title. Eur Respir J 2010; 36: Suppl. 54, abstract number.

Material from 2010:

4910 Abstracts
646 Slide presentations
250 Webcasts
97 Handouts
2124 e-posters
250 Multimedia files

Material from 2010: Show

Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach

E-Communication Session
Chairs: T. Mairinger (Berlin, Germany), R. G. Wiewrodt (Muenster, Germany)

Download all media

Late Breaking Abstract: A genome-wide association study identifies variants at 12q13.3-q14.1 as genetic risk factors for sarcoidosis S. Hofmann, A. Fischer, N. Michael, J. Gunnar, P. Rosenstiel, K. Gaede, M. Schürmann, J. Müller-Quernheim, S. Schreiber (Kiel, Borstel, Lübeck, Freiburg, Germany)
Late Breaking Abstract: Real-time PCR versus direct sequencing in detection of EGFR T790M and L858R mutations – The sensitivity comparison M. Skronski, P. Jagus, A. Szpechcinski, R. Struniawski, J. Chorostowska-Wynimko (Warsaw, Poland)
Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers R. Young, R. Hopkins, B. Hay, C. Whittington, G. Gamble (Auckland, New Zealand)
COPD susceptibility gene on chromosome 4q31 is also associated with lung cancer R. Young, R. Hopkins, B. Hay, C. Whittington, G. Gamble (Auckland, New Zealand)
The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema W. Janssens, I. Buysschaert, P. Zanen, J. Coolen, N. Lays, H. Cuppens, H. Groen, W. Dewever, R. van Klaveren, J. Verschakelen, C. Wijminga, D. Postma, M. Decramer, D. Lambrechts (Leuven, Belgium; Utrecht, Groningen, Rotterdam, Netherlands)
Fine mapping of matrix metalloproteinase 16 (MMP16) gene: Validation of a significant association with bronchopulmonary dysplasia (BPD) A. Hadchouel Duvergé, F. Decobert, I. Layouni, P. H. Jarreau, R. Lenclen, M. L. Franco-Montoya, J. Bourbon, C. Delacourt (Créteil, Paris, Poissy, France)
(Array)CGH analysis of chromosomal gains and losses in human malignant pleural mesothelioma cell lines: Involved loci and genes M. A. Hoda, C. Pirker, E. Felley-Bosco, A. Mohamed, B. Ghanim, B. Hegedus, W. Klepetko, W. Berger (Austria; Zurich, Switzerland)
Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer R. Young, R. Hopkins, J. Field, B. Hay, P. Black, G. Gamble (Auckland, New Zealand; , United Kingdom)
Genomic changes detected by oligo-array in malignant pleural effusion L. D. Kulikowski, D. C. B. Rosolen, G. Bottura, F. S. Vargas, R. K. Sales, L. Antonangelo (Sao Paulo, Brazil)
Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion M. Botana, D. Valverde, L. de Chiara, V. Leiro, A. Pallarés, C. Represas, I. Pereiro, A. Fernández-Villar (Vigo, Spain)
The profibrotic role of mir-154 family in lung fibrosis J. Milosevic, K. Pandit, M. Magister, A. Bais, E. Rabinovich, P. Benos, A. Tzouvelekis, N. Kaminski (Pittsburgh, United States Of America; Alexandroupolis, Greece)
The global microRNA profile of idiopathic pulmonary fibrosis K. Pandit, J. Milosevic, P. Benos, N. Kaminski (Pittsburgh, United States Of America)
HLA-DRB1 allele frequencies in Finnish sarcoidosis patients and associations with disease prognosis A. Wennerström, A. Pietinalho, H. Vauhkonen, E. Lahtela, J. Hedman, M. Purokivi, E. Varkki, M. Seppänen, M. L. Lokki, O. Selroos (Helsinki, Lappeenranta, Kuopio, Oulu, Finland; Vejbystrand, Sweden)